BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$255B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$288M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 5 |
Advanced Micro Devices
AMD
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$622M |
| 2 |
Microsoft
MSFT
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 4 |
Amazon
AMZN
|
+$353M |
| 5 |
Diageo
DEO
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.42% |
| 2 | Financials | 6.29% |
| 3 | Healthcare | 5.84% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
MP Materials
MP
$10.5B
| $3.12M | 0.01% |
+114,380
| New | +$3.74M |
|
1427
AngloGold Ashanti
AU
$48.7B
| $3.12M | 0.01% |
225,885
+102,015
| +82% | +$1.45M |
|
|
DCPH
1428
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.12M | 0.01% |
168,579
+105,894
| +169% | +$1.66M |
|
1429
Paylocity
PCTY
$7.87B
| $3.12M | 0.01% |
12,897
+2,276
| +21% | +$523K |
|
1430
Radian Group
RDN
$4.98B
| $3.12M | 0.01% |
161,494
+62,214
| +63% | +$1.33M |
|
1431
Allogene Therapeutics
ALLO
$708M
| $3.11M | 0.01% |
288,390
+256,934
| +817% | +$3.49M |
|
1432
Aramark
ARMK
$16.4B
| $3.11M | 0.01% |
138,208
+46,770
| +51% | +$1.16M |
|
1433
Allegion
ALLE
$14B
| $3.11M | 0.01% |
34,678
-44,717
| -56% | -$4.43M |
|
1434
Tilray
TLRY
$636M
| $3.1M | 0.01% |
112,891
+67,889
| +151% | +$2.38M |
|
1435
RLI Corp
RLI
$5.85B
| $3.1M | 0.01% |
60,572
-21,020
| -26% | -$1.18M |
|
|
TMHC
1436
DELISTED
Taylor Morrison
TMHC
| $3.1M | 0.01% |
132,886
+55,392
| +71% | +$1.44M |
|
1437
TransUnion
TRU
$15.4B
| $3.1M | 0.01% |
52,036
+3,495
| +7% | +$269K |
|
|
BRSL
1438
Brightstar Lottery PLC
BRSL
$2.17B
| $3.09M | ﹤0.01% |
195,608
+12,547
| +7% | +$235K |
|
1439
CALL
Petrobras Class A
PBR.A
$104B
| $3.08M | ﹤0.01% |
+2,500
| New | +$30.1K |
|
1440
New Jersey Resources
NJR
$5.64B
| $3.08M | ﹤0.01% |
79,654
+23,181
| +41% | +$1.03M |
|
1441
Acadia Pharmaceuticals
ACAD
$4.87B
| $3.08M | ﹤0.01% |
188,163
+133,376
| +243% | +$2.16M |
|
1442
Sony
SONY
$142B
| $3.07M | ﹤0.01% |
239,605
+131,770
| +122% | +$2.11M |
|
1443
Commault Systems
CVLT
$6.1B
| $3.06M | ﹤0.01% |
57,678
+19,369
| +51% | +$1.1M |
|
1444
PUT
3M
MMM
$94.2B
| $3.05M | ﹤0.01% |
330
+79
| +31% | +$8.66K |
|
|
MZTI
1445
The Marzetti Company
MZTI
$3.18B
| $3.04M | ﹤0.01% |
20,229
+11,339
| +128% | +$1.68M |
|
1446
Exponent
EXPO
$3.19B
| $3.04M | ﹤0.01% |
34,647
+19,198
| +124% | +$1.82M |
|
|
FLG
1447
Flagstar Bank National Association
FLG
$5.92B
| $3.03M | ﹤0.01% |
118,254
-3,449
| -3% | -$101K |
|
1448
Wipro
WIT
$19.2B
| $3.03M | ﹤0.01% |
1,284,740
+12,044
| +0.9% | +$31.2K |
|
1449
BioCryst Pharmaceuticals
BCRX
$2.49B
| $3.02M | ﹤0.01% |
239,880
+199,198
| +490% | +$2.56M |
|
|
BBBY
1450
Bed Bath & Beyond
BBBY
$415M
| $3.01M | ﹤0.01% |
135,961
+52,352
| +63% | +$1.31M |
|
Similar funds
BNP Paribas Financial Markets's Q3 2022 Portfolio in Review
As of Q3 2022, BNP Paribas Financial Markets held 5,152 positions worth $62.5B, down 2.4% from $64.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
BNP Paribas Financial Markets deployed $254B of net new capital in Q3 2022, opening 1,204 new positions and adding to 1,887 existing holdings. Its largest new stake was Marvell Technology: 910,010 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $622M trimmed.
- BNP Paribas Financial Markets's largest Q3 2022 buy was Marvell Technology: 910,010 shares worth $39M.
- BNP Paribas Financial Markets added most to Berkshire Hathaway Class A in Q3 2022, an estimated $255B increase.
- BNP Paribas Financial Markets's biggest Q3 2022 reduction was Apple, cutting an estimated $622M.
- BNP Paribas Financial Markets fully exited Alphabet (Google) Class A in Q3 2022, selling an estimated $533M.
- BNP Paribas Financial Markets's ten largest holdings make up 12% of its $62.5B portfolio in Q3 2022.
- BNP Paribas Financial Markets opened 1,204 new positions and closed 420 in Q3 2022.
- BNP Paribas Financial Markets's portfolio value fell 2.4% quarter-over-quarter to $62.5B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.